Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 2, 2000, Pages 868-872

  Brown, Suzanne B ^a   Brierley, Tamika T ^a   Palanisamy, Nallasivam ^b   Salusky, Isidro B ^c   Goodman, William ^c   Brandi, Maria Luisa ^d   Drüeke, Tilman B ^e   Sarfati, Emile ^f   Ureña, Pablo ^e   Chaganti, R S K ^b   Pike, J Wesley ^g   Arnold, Andrew ^a,h  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF FLORENCE   (Italy)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g UNIVERSITY OF CINCINNATI   (United States)

^h UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE INACTIVATION; GENE LOCUS; GENETIC DISORDER; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; PARATHYROID CELL; PARATHYROID TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE; UREMIA;

ADULT; ALLELES; BASE SEQUENCE; CHROMOSOMES; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; HYPERPARATHYROIDISM, SECONDARY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; UREMIA;

EID: 17744385121     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.2.868     Document Type: Article

References (46)

1. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia
2. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism
3. Pathogenesis of endocrine tumors
4. A novel cyclin encoded by a bcl1-linked candidate oncogene
5. Somatic mutation of the MEN1 gene in parathyroid tumors
6. Molecular basis of primary hyperparathyroidism
7. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism
8. Alterations of the MEN1 gene in sporadic parathyroid tumors
9. Vitamin D and the parathyroid
10. Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure
11. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients
12. 3 in the parathyroid glands of patients with renal failure
13. 3 receptors in experimental uremia
14. 2D receptors are decreased in parathyroid glands from chronically uremic dogs
15. 3 receptor expression in uraemic parathyroid tissue
16. Apa I, Bsm I, Eco RV and Taq I polymorphisms at the human vitamin D receptor gene locus in caucasians, blacks and asians
17. Prediction of bone density from vitamin D receptor alleles
18. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women
19. Structural organization of the human vitamin D receptor chromosomal gene and its promoter
20. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
21. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas
22. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: Utility of single-strand conformation polymorphism analysis for heterozygous carrier detection
23. The vitamin D receptor start codon polymorphism (Fok I) and bone mineral density in premenopausal American black and white women
24. A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women
25. The human vitamin D receptor gene (VDR) is localized to region 12cen-q12 by fluorescent in situ hybridization and radiation hybrid mapping: Genetic and physical VDR map
26. Parathyroidectomy for hyperparathyroidism in maintenance dialysis patients
27. Hyperparathyroidism in renal failure: Clinical features, diagnosis, and management
28. The dilemma of parathyroidectomy in chronic renal failure
29. Tertiary hyperparathyroidism and refractory secondary hyperparathyroidism
30. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue
31. Abnormal calcium-regulated PTH release in normal parathyroid tissue from patients with adenoma
32. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11
33. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients
34. DNA ploidy pattern of parathyroid parenchymal cells in renal secondary hyperparathyroidism with relapse
35. The molecular biology of parathyroid disease
36. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism
37. Expression of proliferating cell nuclear antigens in parathyroid glands of renal hyperparathyroidism
38. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism
39. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism
40. 3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells
41. 3 of cell proliferation and function of bovine parathyroid cells in culhare
42. 3 inhibits parathyroid cell proliferation in experimental uremia
43. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors
44. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure
45. Influence of vitamin D receptor genotype on bone mass changes after renal transplantation
46. Genetic abnormahties in parathyroid nodules of uremic patients